Erdem Tüzün

Prof. Dr. Erdem Tüzün

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2009 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
ETErdem Tüzün
Erdem Tüzün
LZLei Zhou
Lei Zhou
JBJoachim M. Baehring
Joachim M. Baehring
SBSerguei Bannykh
Serguei Bannykh
MRMyrna R. Rosenfeld
Myrna R. Rosenfeld
JDJosep Dalmau
Josep Dalmau

21 March 2014 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
CKCem İsMail Küçükali
Cem İsMail Küçükali
MKMurat Kürtüncü
Murat Kürtüncü
AÇArzu Çoban
Arzu Çoban
MÇMerve Çebi
Merve Çebi
ETErdem Tüzün
Erdem Tüzün

16 June 2014 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
ESErkingul Shugaiv
Erkingul Shugaiv
ETErdem Tüzün
Erdem Tüzün
MKMurat Kürtüncü
Murat Kürtüncü
AKAslı Kıyat-Atamer
Aslı Kıyat-Atamer
AÇArzu Çoban
Arzu Çoban
MEMefkure Eraksoy
Mefkure Eraksoy
Uveitis is occasionally encountered in multiple sclerosis (MS) patients. The objective of this report is to investigate whether uveitis has a prognostic impact on the clinical course of MS. Several clinical and demographic features were compared between 41 MS patients with uveitis and 100 randomly selected MS patients without uveitis. While there were no significant differences by means of gender, age of MS onset, oligoclonal band positivity and disease duration, EDSS and progression index (PI) scores of MS patients with uveitis were significantly lower than those without uveitis (p = 0.004 and <0.001, respectively). Our results suggest that uveitis might be used as a good prognostic factor.

1 January 2011 in Neurology India
Verified
Journal Article
Closed access
PDF file
ETErdem Tüzün
Erdem Tüzün
EEEce Erdağ
Ece Erdağ
HDHacer Durmuş
Hacer Durmuş
TBTanja Brenner
Tanja Brenner
RTRecai Türkoğlu
Recai Türkoğlu
AVAngela Vincent
Angela Vincent
Background : Thyroid antibodies (Thy-Abs) are frequently detected in various autoimmune disorders in coexistence with other systemic autoantibodies. In association with an encephalopathy, they are often taken as evidence of Hashimoto's encephalitis (HE). However, the presence of Thy-Abs in a cohort of limbic encephalitis (LE) patients and their association with anti-neuronal autoimmunity has not been explored. Patients and Methods : We investigated thyroid and anti-neuronal antibodies in the sera of 24 LE patients without identified tumors by cell-based assay and radioimmunoassay and evaluated their clinical features. Results : There was a female predominance in Thy-Ab-positive LE patients. Five of the eight Thy-Ab-positive patients and six of the 16 Thy-Ab-negative patients had antibodies to voltage-gated potassium channel (VGKC), N-methyl-D-aspartate receptor (NMDAR) or undefined surface antigens on cultured hippocampal neurons. There were trends towards fewer VGKC antibodies (1/8 vs. 5/16, P = 0.159) and more NMDAR antibodies (2/8 vs. 1/16, P = 0.095) among the Thy-Ab-positive LE patients; antibodies to undefined surface antigens were only identified in Thy-Ab-positive patients (2/8 vs. 0/16, P = 0.018). There were no distinguishing clinical features between Thy-Ab-positive patients with and without neuronal antibodies. However, patients with anti-neuronal antibodies showed a better treatment response. Conclusion : Thy-Abs can be found in a high proportion of patients with non-paraneoplastic LE, often in association with antibodies to specific or as yet undefined neuronal surface antigens. These results suggest that acute idiopathic encephalitis patients with Thy-Abs should be closely monitored for ion-channel antibodies and it should not be assumed that they have HE.

31 May 2019 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
FAFeyza Aricioglu
Feyza Aricioglu
COCeren Sahin Ozkartal
Ceren Sahin Ozkartal
TBTugce Bastaskin
Tugce Bastaskin
ETErdem Tüzün
Erdem Tüzün
CKCansu Kandemir
Cansu Kandemir
TUTijen Utkan
Tijen Utkan
Feyza Aricioglu, Ceren Sahin Ozkartal, Tugce Bastaskin, Erdem Tüzün, Cansu Kandemir, Serap Sirvanci, Cem Ismail Kucukali, Tijen Utkan. Clin Psychopharmacol Neurosci 2019;17:261-72. https://doi.org/10.9758/cpn.2019.17.2.261

30 October 2012 in Cephalalgia
Verified
Journal Article
Closed access
PDF file
MKMurat Kürtüncü
Murat Kürtüncü
DKDilaver Kaya
Dilaver Kaya
LZLuigi Zuliani
Luigi Zuliani
EEEce Erdağ
Ece Erdağ
SISema İçÖz
Sema İçÖz
ETErdem Tüzün
Erdem Tüzün
Background Patients with the syndrome of headache with neurological deficits and lymphocytosis (HaNDL) typically present with recurrent and temporary attacks of neurological symptoms and cerebrospinal fluid lymphocytosis. Aim and methods To identify potential HaNDL‐associated antibodies directed against neuronal surface and/or synapse antigens, sera of four HaNDL patients and controls were screened with indirect immunohistochemistry, immunofluorescence, cell-based assay, radioimmunoassay, protein macroarray and enzyme-linked immunosorbent assay (ELISA). Results Although HaNDL sera did not yield antibodies to any of the well-characterized neuronal surface or synapse antigens, protein macroarray and ELISA studies showed high-titer antibodies to a subunit of the T-type voltage-gated calcium channel (VGCC), CACNA1H, in sera of two HaNDL patients. Conclusion Our results support the notion that ion channel autoimmunity might at least partially contribute to HaNDL pathogenesis and occurrence of neurological symptoms.